Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07773714Phase 1Completed
Phase 1, randomised trial of curodont in White spot lesion (WSL) (2 arms), sponsored by Suez Canal University. Primary endpoints: Number of Participants with White Spot Lesions post orthodontic treatment assessed by Delta E at 1 year and Delta E at 1 year. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07773714.